A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors
Clinical trial NCT04303858 · TERMINATED
Trial details
- NCT number
- NCT04303858
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-04
- Primary completion
- 2025-10-02
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.